You Position: Home > Paper
Changes of the serum visfatin level and its relationships to the inflammatory factors after treatment of type 2 diabetes mellitus
( views:407, downloads:180 )
- Author:
- No author available
- Journal Title:
- CHINESE JOURNAL OF DIABETES
- Issue:
- 6
- DOI:
- 10.3969/j.issn.1006-6187.2010.06.009
- Key Word:
- 内脏脂肪素;糖尿病,2型;炎症因子;胰岛素抵抗;肥胖
Abstract： 目的 了解2型糖尿病(T2DM)患者治疗前后血清内脏脂肪素(Visfatin)水平的变化及其与炎症因子的关系. 方法 选取T2DM患者44例,用胰岛素泵强化治疗12~15d,同时给予调脂、降压等综合治疗.记录人体测量参数.监测治疗前后生化指标及空腹血清Visfatin、肿瘤坏死因子-α(TNF-α)、白介素-6(IL-6)的变化. 结果 治疗后血清Visfatin水平由(10.62±2.44)μg/L降至(8.38±1.72)μg/L,差异有统计学意义(P<0.01).Pearson相关分析显示,治疗后血清Visfatin的下降值与WC、WHR以及TG、LDL-C、FBG、hsC-RP、TNF-α和IL-6的下降值呈正相关.多元逐步回归分析显示,WHR是影响Visfatin下降的独立相关因素. 结论 T2DM患者治疗后血清Visfatin水平较治疗前显著下降,且与其他血清炎症因子的下降正相关,提示Visfatin可能在T2DM的发生发展中起重要作用.
- [1]丁焕发,荣海钦,季虹,等.2型糖尿病患者血清内脏脂肪素水平及其影响因素[J].2009,(4).
- [2]Visvikis-Siest S,Samara A,Pfister M,etc.Visfatin, low-grade inflammation and body mass index (BMI).[J].2008,69(4).
- [3]Baldi I,Ciccone G,Bo S.Plasma visfatin concentrations after a lifestyle intervention were directly associated with inflammatory markers.[J].2009,19(6).
- [4]Kennedy CR,Randeva HS,Tan BK,etc.Increased visfatin messenger ribonucleic acid and protein levels in adipose tissue and adipocytes in women with polycystic ovary syndrome: parallel increase in plasma visfatin.[J].2006,91(12).